Skip to main content

Table 2 Change in clinical characteristic at baseline and post-surgery

From: Effect of Roux-en-Y gastric bypass on patients with type 2 diabetes mellitus and body mass index of 27.5–35 kg/m2–a single center retrospective cohort study

 

Baseline

3 months

12 months

BMI (kg/m2)

30.90 ± 1.75

25.40 ± 2.17**

24.40 ± 3.26***

SBP (mmHg)

135.32 ± 12.01

128.51 ± 10.63*

122.18 ± 12.26*

DBP (mmHg)

86.61 ± 11.41

83.41 ± 6.98*

81.30 ± 4.18*

HDL (mmol/l)

1.01 ± 0.29

1.36 ± 0.42*

1.22 ± 0.47

LDL (mmol/l)

2.37 ± 1.03

2.16 ± 0.63*

2.17 ± 0.81

TC (mmol/l)

4.89 ± 1.10

4.84 ± 0.77

4.59 ± 0.84**

TG (mmol/l)

4.04 ± 1.41

1.11 ± 0.68*

0.93 ± 0.46**

HbA1c (%)

8.65 ± 1.89

6.18 ± 1.32**

6.17 ± 1.57**

FPG (mmol/l)

9.81 ± 4.02

6.21 ± 2.14*

5.87 ± 1.81***

FINS(µU/ml)

29.27 ± 14.57

28.26 ± 17.34

27.27 ± 18.57*

FCP (ng/ml)

1.78 ± 1.26

2.50 ± 0.25*

2.53 ± 0.44

Peripheral glucose disposal rate (mg/kg/min)

3.23 ± 0.98

6.81 ± 1.81**

7.92 ± 2.01***

Completed remission

-

-

13 (38.2%)

Partial remission

-

-

3 (8.9%)

  1. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides; FPG, fasting plasma glucose; FCP, fasting C-peptide; FINS, fasting insulin. *P < 0.05, ** P < 0.01, *** P < 0.001 vs. baseline